Meta-analysis, decision analysis, and cost-effectiveness analysis methods for quantitative synthesis in medicine
This is a lucid, comprehensive introduction to meta-analysis, decision analysis, and cost-effectiveness analysis. These three closely related methods have become even more important for synthesizing research since the first edition was published in 1994. And they have gained legitimacy as tools for...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
New York
Oxford University Press
2000
|
Edition: | SECOND EDITION |
Series: | Monographs in epidemiology and biostatistics
v. 31 |
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000nam a2200000 i 4501 | ||
---|---|---|---|
001 | wils-272384 | ||
005 | 2020721114718 | ||
008 | t2000 NYU a #0 | ||
020 | # | # | |a 9780195133646 |q hardback |
020 | # | # | |a 0195133641 |q hardback |
040 | # | # | |a DNLM |d UiTM |e rda |
041 | 0 | # | |a English |
060 | 0 | 0 | |a WA 950 |
090 | 0 | 0 | |a WA950 |b P491m 2000 |
100 | 1 | # | |a Petitti, Diana B. |e author |
245 | 1 | 0 | |a Meta-analysis, decision analysis, and cost-effectiveness analysis |b methods for quantitative synthesis in medicine |c Diana B. Petitti |
250 | # | # | |a SECOND EDITION |
264 | # | 1 | |a New York |b Oxford University Press |c 2000 |
264 | # | 4 | |c ©2000 |
300 | # | # | |a x, 303 pages |b illustrations |c 23 cm |
336 | # | # | |a text |b txt |2 rdacontent |
337 | # | # | |a unmediated |b n |2 rdamedia |
338 | # | # | |a volume |b nc |2 rdacarrier |
490 | 1 | # | |a Monographs in epidemiology and biostatistics |v v. 31 |
504 | # | # | |a Includes bibliographical references and index |
520 | # | # | |a This is a lucid, comprehensive introduction to meta-analysis, decision analysis, and cost-effectiveness analysis. These three closely related methods have become even more important for synthesizing research since the first edition was published in 1994. And they have gained legitimacy as tools for guiding health policy. In the Second Edition, Petitti has added new material on cumlative meta-analysis and the exploration of heterogeneity, incorporated recommendations for standardizing the conduct of cost-effectiveness analysis, and updated the rest of the text |
650 | 1 | 2 | |a Meta-Analysis as Topic |
650 | 2 | 2 | |a Cost-Benefit Analysis |x statistics & numerical data |
650 | 2 | 2 | |a Decision Support Techniques |
856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=272384 |
964 | # | # | |c BOK |d 01 |
998 | # | # | |a 00250##a002.5.2||00250##b002.5.3||00264#1a002.8.2||00264#1b002.8.4||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00520##a007.2||00520##b007.2|| |